IRIS
CIMMINO, FLORA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 359
EU - Europa 231
AS - Asia 85
AF - Africa 6
Totale 681
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 351
IT - Italia 146
SG - Singapore 60
NL - Olanda 38
CN - Cina 22
IE - Irlanda 15
CA - Canada 8
CI - Costa d'Avorio 6
DE - Germania 6
ES - Italia 6
FI - Finlandia 5
FR - Francia 5
UA - Ucraina 5
IN - India 3
SE - Svezia 2
AT - Austria 1
BG - Bulgaria 1
GB - Regno Unito 1
Totale 681
Salva come PNG Salva come JPEG
Città #
Chandler 83
Singapore 54
Naples 40
Amsterdam 36
Ashburn 29
Napoli 20
Santa Clara 13
Dublin 11
Lawrence 11
Millbury 10
Boston 9
Des Moines 9
Beijing 7
Nanjing 7
Ottawa 6
Wilmington 6
Princeton 4
Shenyang 4
Frankfurt am Main 3
Genova 3
Houston 3
Jacksonville 3
Milan 3
Nocera Inferiore 3
Sant'agata De' Goti 3
Brusciano 2
Kronberg 2
Pune 2
Redwood City 2
Rovigo 2
San Mateo 2
Woodbridge 2
Almere Stad 1
Bari 1
Borås 1
Catania 1
Duncan 1
Fairfield 1
Hebei 1
Helsinki 1
Imola 1
Latina 1
Leawood 1
Los Angeles 1
Lund 1
Marigliano 1
Monmouth Junction 1
Mugnano di Napoli 1
Nanchang 1
Nashville 1
Porto Sant'elpidio 1
Pozzuoli 1
Rome 1
Salerno 1
San Giovanni la Punta 1
Somma Vesuviana 1
Tianjin 1
Totale 419
Salva come PNG Salva come JPEG
Nome #
Neural crest-derived tumor neuroblastoma and melanoma share 1p13.2 as susceptibility locus that shows a long-range interaction with the SLC16A1 gene 85
An 18 gene expression-based score classifier predicts the clinical outcome in stage 4 neuroblastoma 74
HIF-1 transcription activity: HIF1A driven response in normoxia and in hypoxia 61
Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression 57
A high-content screening of anticancer compounds suggests the multiple tyrosine kinase inhibitor ponatinib for repurposing in neuroblastoma therapy 56
Inhibition of hypoxia inducible factors combined with all-trans retinoic acid treatment enhances glial transdifferentiation of neuroblastoma cells 54
Perspectives on liquid biopsy for label‐free detection of “circulating tumor cells” through intelligent lab‐on‐chips 52
Fine mapping of 2q35 high-risk neuroblastoma locus reveals independent functional risk variants and suggests full-length BARD1 as tumor-suppressor 44
Proteomic alterations in response to Hypoxia Inducible Factor 2α in normoxic Neuroblastoma cells 37
Label-free microfluidic platform for blood analysis based on phase-contrast imaging 37
Tomographic flow cytometry as the key-enabling technology for label-free liquid biopsy 36
FGFR1 is a potential therapeutic target in neuroblastoma 35
Exploring shared susceptibility between two neural crest cells originating conditions: Neuroblastoma and congenital heart disease 30
Dualistic role of BARD1 in cancer 28
Functional annotation and investigation of the 10q24.33 melanoma risk locus identifies a common variant that influences transcriptional regulation of OBFC1 28
Raw holograms based machine learning for cancer cells classification in microfluidics 17
PBMCs as Tool for Identification of Novel Immunotherapy Biomarkers in Lung Cancer 6
Totale 737
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.225
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.225
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202039 0 0 0 0 0 12 6 0 0 3 14 4
2020/202151 4 7 13 2 2 7 3 1 4 2 6 0
2021/2022113 0 5 6 3 0 1 3 1 6 13 39 36
2022/2023202 16 10 5 16 25 27 2 23 35 34 8 1
2023/2024141 4 24 40 7 0 23 1 15 0 0 14 13
2024/202586 25 40 6 3 12 0 0 0 0 0 0 0
Totale 737